Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Inosine and Mycophenolic Acid

supplement:

Inosine

Research Papers that Mention the Interaction

BACKGROUND Mycophenolic acid is reported to provide effective immunosuppression by inhibiting inosine monophosphate dehydrogenase.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  •  2002  |  View Paper
Mycophenolic acid is reported to provide effective immunosuppression by inhibiting inosine monophosphate dehydrogenase.
Clinical pharmacology and therapeutics  •  2001  |  View Paper
Mycophenolic acid and mizoribine inhibit inosine monophosphate dehydrogenase, thereby depleting guanosine nucleotides.
Immunopharmacology  •  2000  |  View Paper
Here, we successfully induced the in vitro formation of Toxoplasma cysts-like structures from tachyzoites of the type I RH strain by treating with mycophenolic acid , an inhibitor of the inosine monophosphate dehydrogenase.
Parasitology Research  •  2017  |  View Paper
MPA exerts its immunosuppression by inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH), depleting activated lymphocytes of guanine nucleotides and retarding their proliferation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  •  2015  |  View Paper
Mycophenolic acid MPA ) is a selective inhibitor of inosine 5′-monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme of de novo synthesis of guanine nucleotides.
The Pharmacogenomics Journal  •  2010  |  View Paper
Mycophenolic acid , the active metabolite of MMF, selectively inhibits inosine 5’-monophosphate dehydrogenase, a key enzyme of the purine de novo synthesis pathway of guanosine nucleotides [1].
Swiss medical weekly  •  2009  |  View Paper
MPA , a fermentation product of Penicillium brevicompactum and related fungi, is an inhibitor of inosine monophosphate dehydrogenase, a key enzyme in the de novo pathway of purine synthesis.
Clinical journal of the American Society of Nephrology : CJASN  •  2007  |  View Paper
BACKGROUND The mechanism of action of mycophenolic acid (MPA) has been described as a blockade of inosine 5'-monophosphate dehydrogenase (IMPDH) and is thought to selectively influence T- and B-lymphocytes due to their strong dependency on guanine nucleotides synthesized via the de novo purine synthesis pathway.
Clinica chimica acta; international journal of clinical chemistry  •  2006  |  View Paper
MPA is a well-known inhibitor of inosine monophosphate dehydrogenase and anti-HIV activity has been reported in vitro and in vivo.
The Journal of Antibiotics  •  2005  |  View Paper
Show More